Table 5 T/L measured for nine lung tumors as a function of the time elapsed after radiopharmaceutical administration. In bracket, we indicated the patient identifier

T1 (P1)

2.22

2.32

2.42

2.37

2.49

2.35

2.39

T2 (P3)

2.58

3.04

3.43

3.03

3.71

3.65

3.39

T3 (P3)

2.67

3.88

4.44

4.14

4.86

5.06

4.65

T4 (P4)

4.60

5.72

5.89

6.19

6.75

6.62

6.59

T5 (P4)

4.90

6.04

6.23

6.65

7.21

7.08

7.08

T6 (P5)

1.74

2.42

2.67

2.93

2.75

2.77

2.71

T7 (P5)

5.79

8.41

9.27

9.21

8.90

8.90

8.87

T8 (P5)

1.78

2.00

2.09

2.06

2.14

2.07

2.00

T9 (P6)

5.32

5.06

4.89

5.22

5.17

5.89

5.65

Average

3.51

4.32

4.59

4.65

4.89

4.93

4.81

SD

1.62

2.15

2.30

2.38

2.35

2.38

2.39